Neuroendocrine Tumors in Meckel’s Diverticulum: Recommendation for Lymphadenectomy Regardless of Tumor Size Based on the NCDB Experience
- 16 Downloads
Meckel’s diverticulum (MD) is an anomaly of the small intestine from which malignancy may arise. Among MD neoplasms, neuroendocrine tumors (NETs) are considered the most common. However, their metastatic potential and optimal surgical therapy remain ill-defined.
In a retrospective analysis of the National Cancer Database (2004–2015), patients with a diagnosis of MD malignancy were identified. Clinicopathologic factors were extracted and tumors arising in MD were compared. In the subgroup of patients with NET, the association between tumor factors and node involvement was investigated.
Three hundred twenty primary MD malignancies were captured in the National Cancer Database, consisting of 280 (87.5%) NET. The median age at diagnosis was 64 years. Patients were predominantly male (207, 73.9%) and white (269, 96.1%). Most tumors were well-differentiated (118, 42.1%) and sub-centimeter (median size, 0.7 cm). Distant metastasis was present in a minority (16, 5.7%), and the median overall survival was 114 months in the entire cohort. The regional lymph node status was known in 87 NET patients, out of which 39 (44.8%) harbored node metastasis. Although the risk of node involvement increased with larger tumor size, it remained significant even among sub-centimeter (9 out of 34, 26.5%) and well-differentiated (18 out of 44, 41%) tumors. Regional node involvement was associated with the presence of distant metastasis (p < 0.001).
Lymph node involvement was common irrespective of the size and grade of NET arising from Meckel’s diverticulum. Therefore, regional lymphadenectomy should be considered in the curative-intent surgical management of these neoplasms regardless of tumor size and grade.
KeywordsNeuroendocrine tumors Carcinoid Meckel’s diverticulum Small bowel Small intestine Lymphadenectomy Lymph nodes
Design of the work: Dogeas, Magallanes, Augustine
Acquisition of data: Dogeas, Magallanes, Augustine
Interpretation of data: Dogeas, Magallanes, Porembka, Wang, Yopp, Polanco, Mansour, Choti, Zeh, Augustine
Drafting the work: Dogeas, Magallanes, Augustine
Final approval: Dogeas, Magallanes, Porembka, Wang, Yopp, Polanco, Mansour, Choti, Zeh, Augustine
Agreement to be accountable for all aspects of the work: Dogeas, Magallanes, Porembka, Wang, Yopp, Polanco, Mansour, Choti, Zeh, Augustine
Compliance with Ethical Standards
Sources of Support
Disclosure of Funding
- 5.National Comprehensive Cancer Network. Neuroendocrine tumor (Version 2.2018). https://www.nccn.org/professionals/physician_gls/PDF/neuroendocrine.pdf. Accessed May 4, 2018
- 7.Anderson D. Carcinoid tumor in Meckel’s diverticulum: laparoscopic treatment and review of the literature, JAOA, 2000, 100, 432–434Google Scholar
- 9.Boffa D, et al, Using the National Cancer Database for Outcomes Research: A Review, JAMA Oncology, 2017, E1-E6Google Scholar
- 10.Shi C, Adsay V, Washington MK. Protocol for the Examination of Specimens From Patients with Neuroendocrine Tumor of the Jejunum and Ileum, 8th Edition AJCC Staging Manual, June 2017Google Scholar
- 11.Chan JA, Kulke MH, Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy, Surg Oncol Clin N Am, 2016, 25, 423–437Google Scholar